Saudi Chemical Holding Company

TADAWUL:2230.SR

11.38 (SAR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 4,854.8483,695.8683,410.983,306.162,949.1682,948.5322,481.5692,146.0312,409.7732,484.3152,275.1212,001.3331,867.5731,687.3421,643.3371,537.1571,230.134
Cost of Revenue 4,194.9343,208.2132,979.0792,847.0012,491.2062,538.0882,086.0641,740.811,916.781,981.5191,795.6351,526.8191,434.161,313.2441,297.0511,271.311,023.796
Gross Profit 659.914487.655431.901459.159457.962410.444395.505405.221492.993502.796479.486474.514433.413374.098346.286265.847206.338
Gross Profit Ratio 0.1360.1320.1270.1390.1550.1390.1590.1890.2050.2020.2110.2370.2320.2220.2110.1730.168
Reseach & Development Expenses 00000000000000000
General & Administrative Expenses 48.21535.73535.65427.116132.654116.164110.456102.341114.24696.17785.62184.41768.6680132.79140.73740.892
Selling & Marketing Expenses 63.51954.80240.19235.591149.437114.11494.46487.39487.56492.11978.39267.15565.2640000
SG&A 342.57290.53775.84662.707309.694206.981191.268181.263200.186188.296164.013151.572133.9320132.79140.73740.892
Other Expenses -2.2243.04212.059221.477-333.475-226.509-206.453-8.101-209.9243.16616.8281.4810.91510.3635.9835.931-27.884
Operating Expenses 342.572310.245287.905284.184-333.475-226.509-206.453-8.101-209.924188.296164.013151.572133.93261.36716.64546.66848.545
Operating Income 317.342177.41142.913149.769124.487183.935189.052197.138283.069314.5315.473322.942299.481312.731323.172-46.668-48.545
Operating Income Ratio 0.0650.0480.0420.0450.0420.0620.0760.0920.1170.1270.1390.1610.160.1850.197-0.03-0.039
Total Other Income Expenses Net -103.414-63.243-36.076-41.521-58.251-41.049-197.202-32.905-2.147-1.65210.446-4.324-3.7337.172628.471459.142283.487
Income Before Tax 213.928114.167106.837108.24866.236142.886-8.15164.233280.922312.848325.919318.618295.748319.903951.643412.474234.942
Income Before Tax Ratio 0.0440.0310.0310.0330.0220.048-0.0030.0770.1170.1260.1430.1590.1580.190.5790.2680.191
Income Tax Expense 33.66833.1836.37433.20132.80326.893-151.24826.41729.29127.99624.02825.7826.97515.40245.27822.81222.78
Net Income 182.88680.22369.5774.02632.877115.993143.098137.816251.631283.561300.603291.279267.404303.171301.019200.534111.776
Net Income Ratio 0.0380.0220.020.0220.0110.0390.0580.0640.1040.1140.1320.1460.1430.180.1830.130.091
EPS 0.220.0950.0830.0880.0390.140.170.160.30.340.360.350.320.360.360.240.13
EPS Diluted 0.220.0950.0830.0880.0390.140.170.160.30.340.360.350.320.360.360.240.13
EBITDA 363.738213.311196.037222.224123.291184.20516.152189.037290.611330.142334.266342.551318.109329.494343.175229.862167.687
EBITDA Ratio 0.0750.0580.0570.0670.0420.0620.0070.0880.1210.1330.1470.1710.170.1950.2090.150.136